Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine nasal spray to prevent postoperative delirium after lower limb fracture surgery in elderly patients
ChiCTR2500114122Phase 4Not yet recruiting
- Sponsor
- Shanghai General Hospital
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in postoperative delirium (POD) (2 arms), sponsored by Shanghai General Hospital. Primary endpoint: Delirium incidence within 5 days after surgery. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2500114122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114122.